# PDE6B

## Overview
The PDE6B gene encodes the β-subunit of the rod photoreceptor cGMP phosphodiesterase, a critical enzyme in the phototransduction pathway of the retina. This enzyme is a key player in the conversion of light signals into electrical signals, a process essential for vision. The protein phosphodiesterase 6B (PDE6b) is a component of a heterodimeric complex that includes the α-subunit encoded by the PDE6A gene, and it functions by hydrolyzing cyclic guanosine monophosphate (cGMP) in response to light activation (Maryam2019The). As a phosphodiesterase, PDE6b is involved in regulating cGMP levels, which are crucial for the opening and closing of ion channels in photoreceptor cells, thereby influencing visual signal transduction (Cote2021Photoreceptor). Mutations in the PDE6B gene are linked to retinal diseases such as retinitis pigmentosa and congenital stationary night blindness, underscoring its importance in maintaining retinal health (Watson2021Genetic).

## Structure
The PDE6B protein is a critical component of the rod photoreceptor cGMP phosphodiesterase complex, playing a significant role in the phototransduction pathway. Structurally, PDE6B is part of a heterodimer, consisting of PDE6α and PDE6β subunits, which are encoded by the PDE6A and PDE6B genes, respectively (Maryam2019The). The protein features tandem cGMP-binding regulatory domains, known as GAF domains (Gaf-A and Gaf-B), located in the N-terminal region, and a catalytic domain at the C-terminus (Maryam2019The). These domains are crucial for the protein's function in hydrolyzing cGMP, a key step in visual signal transduction.

The catalytic domain of PDE6B interacts with two metal ions, Mg2+ and Zn2+, which are essential for its enzymatic activity (Maryam2019The). The structure of PDE6B also includes specific residues that form a network of interactions with cGMP, contributing to its binding and hydrolysis (Maryam2019The). The quaternary structure of PDE6B involves its interaction with the inhibitory γ-subunit (Pγ), which regulates its activity by blocking the active site (Barren2009Structural).

PDE6B may exist in different isoforms due to alternative splicing, which can affect its functional properties and interactions within the phototransduction pathway. Common post-translational modifications, such as phosphorylation, may also play a role in modulating its activity and stability.

## Function
The PDE6B gene encodes the β-subunit of cGMP-phosphodiesterase (PDE6b), which is crucial for the phototransduction cascade in retinal photoreceptor cells, particularly in rod cells. In healthy human cells, PDE6b is part of an enzyme complex that hydrolyzes cyclic guanosine monophosphate (cGMP), a process essential for converting light signals into electrical signals in the retina (Tsang2007Transgenic; Gopalakrishna2017Mechanisms). Upon light activation, rhodopsin activates the G-protein transducin, which in turn activates PDE6b by relieving the inhibition imposed by the PDE6g subunit. This activation leads to a decrease in cytoplasmic cGMP levels, resulting in the closure of cGMP-gated cationic channels in the rod plasma membrane and subsequent hyperpolarization of the photoreceptor cell (Tsang2007Transgenic; Cote2021Photoreceptor).

The proper function of PDE6b is critical for normal visual signal transduction, as it regulates cGMP levels, which are vital for the opening and closing of ion channels in the photoreceptor cell membrane (Maryam2019The). This regulation is essential for the transmission of visual signals and the maintenance of visual function in healthy cells (Bolger2021The).

## Clinical Significance
Mutations in the PDE6B gene are associated with several retinal diseases, primarily retinitis pigmentosa (RP) and congenital stationary night blindness (CSNB). Retinitis pigmentosa is a group of inherited disorders characterized by progressive vision loss due to the degeneration of rod photoreceptors. Mutations in PDE6B, such as those affecting the catalytic domain, lead to increased levels of cGMP, resulting in rod cell death and accounting for approximately 4-5% of autosomal recessive RP cases (Watson2021Genetic; McLaughlin1995Mutation). Clinical features include night blindness, constricted visual fields, and eventual loss of both rod and cone function (McLaughlin1995Mutation).

In contrast, autosomal dominant congenital stationary night blindness (adCSNB) is linked to specific mutations in PDE6B that result in truncated proteins interfering with normal photoreceptor function. These mutations, such as p.Tyr314Cysfs*50, cause nonprogressive night blindness with normal day vision by disrupting the inhibitory activity of the γ-subunit of PDE6, leading to constitutive activation of the phototransduction cascade (Manes2014A). The genetic heterogeneity of these conditions highlights the complex role of PDE6B in retinal health and disease (DANCIGER1995Mutations).

## Interactions
PDE6B, a subunit of the rod photoreceptor cGMP phosphodiesterase complex, plays a crucial role in visual transduction by interacting with several proteins. It forms a heterodimer with PDE6A, and together with two inhibitory PDE6G subunits, constitutes the PDE6 holoenzyme. This complex is essential for regulating cGMP levels in photoreceptor cells (ZengElmore2014Molecular).

The interaction between PDE6B and the inhibitory γ-subunit (PDE6G) is critical for its regulation. PDE6G binds to the catalytic sites of the PDE6A and PDE6B dimer, inhibiting cGMP hydrolysis. This interaction is modulated by the presence of cGMP, which affects the binding affinity of PDE6G to the catalytic dimer (Mou2001The).

PDE6B also interacts with the G protein transducin (Gt) during the phototransduction process. Upon activation by light, transducin binds to PDE6, relieving the inhibitory effect of PDE6G and activating the enzyme. This interaction involves the Gt α subunit binding to specific sites on PDE6, facilitating the activation of the catalytic dimer (Irwin2019The; Gao2020Structure).

Mutations in PDE6B, such as Asn 605 Ser, can disrupt these interactions, leading to atypical retinal degeneration by impairing the inhibition of PDE6 by PDE6G (Barren2009Structural).


## References


[1. (Manes2014A) Gaël Manes, Pallavi Cheguru, Anurima Majumder, Béatrice Bocquet, Audrey Sénéchal, Nikolai O. Artemyev, Christian P. Hamel, and Philippe Brabet. A truncated form of rod photoreceptor pde6 β-subunit causes autosomal dominant congenital stationary night blindness by interfering with the inhibitory activity of the γ-subunit. PLoS ONE, 9(4):e95768, April 2014. URL: http://dx.doi.org/10.1371/journal.pone.0095768, doi:10.1371/journal.pone.0095768. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0095768)

[2. (Gopalakrishna2017Mechanisms) Kota N. Gopalakrishna, Kimberly Boyd, and Nikolai O. Artemyev. Mechanisms of mutant pde6 proteins underlying retinal diseases. Cellular Signalling, 37:74–80, September 2017. URL: http://dx.doi.org/10.1016/j.cellsig.2017.06.002, doi:10.1016/j.cellsig.2017.06.002. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2017.06.002)

[3. (DANCIGER1995Mutations) MICHAEL DANCIGER, JOHN BLANEY, Y.Q. GAO, D.Y. ZHAO, JOHN R. HECKENLIVELY, SAMUEL G. JACOBSON, and DEBORA B. FARBER. Mutations in the pde6b gene in autosomal recessive retinitis pigmentosa. Genomics, 30(1):1–7, November 1995. URL: http://dx.doi.org/10.1006/GENO.1995.0001, doi:10.1006/geno.1995.0001. This article has 156 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.1995.0001)

[4. (McLaughlin1995Mutation) M E McLaughlin, T L Ehrhart, E L Berson, and T P Dryja. Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proceedings of the National Academy of Sciences, 92(8):3249–3253, April 1995. URL: http://dx.doi.org/10.1073/pnas.92.8.3249, doi:10.1073/pnas.92.8.3249. This article has 201 citations.](https://doi.org/10.1073/pnas.92.8.3249)

5. (Gao2020Structure) Structure of the Visual Signaling Complex between Transducin and Phosphodiesterase 6. This article has 0 citations.

[6. (Cote2021Photoreceptor) Rick H. Cote. Photoreceptor phosphodiesterase (pde6): activation and inactivation mechanisms during visual transduction in rods and cones. Pflügers Archiv - European Journal of Physiology, 473(9):1377–1391, April 2021. URL: http://dx.doi.org/10.1007/s00424-021-02562-x, doi:10.1007/s00424-021-02562-x. This article has 21 citations.](https://doi.org/10.1007/s00424-021-02562-x)

[7. (Maryam2019The) Arooma Maryam, Sundeep Chaitanya Vedithi, Rana Rehan Khalid, Ali F. Alsulami, Pedro Henrique Monteiro Torres, Abdul Rauf Siddiqi, and Tom L. Blundell. The molecular organization of human cgmp specific phosphodiesterase 6 (pde6): structural implications of somatic mutations in cancer and retinitis pigmentosa. Computational and Structural Biotechnology Journal, 17:378–389, 2019. URL: http://dx.doi.org/10.1016/j.csbj.2019.03.004, doi:10.1016/j.csbj.2019.03.004. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.csbj.2019.03.004)

[8. (Tsang2007Transgenic) Stephen H. Tsang, Michael L. Woodruff, Lin Jun, Vinit Mahajan, Clyde K. Yamashita, Robert Pedersen, Chyuan-Sheng Lin, Stephen P. Goff, Thomas Rosenberg, Michael Larsen, Debora B. Farber, and Steven Nusinowitz. Transgenic mice carrying theh258n mutation in the gene encoding the β-subunit of phosphodiesterase-6 (pde6b) provide a model for human congenital stationary night blindness. Human Mutation, 28(3):243–254, 2007. URL: http://dx.doi.org/10.1002/humu.20425, doi:10.1002/humu.20425. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.20425)

[9. (Mou2001The) Hongmei Mou and Rick H. Cote. The catalytic and gaf domains of the rod cgmp phosphodiesterase (pde6) heterodimer are regulated by distinct regions of its inhibitory γ subunit. Journal of Biological Chemistry, 276(29):27527–27534, July 2001. URL: http://dx.doi.org/10.1074/jbc.m103316200, doi:10.1074/jbc.m103316200. This article has 74 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m103316200)

[10. (Irwin2019The) Michael J. Irwin, Richa Gupta, Xiong-Zhuo Gao, Karyn B. Cahill, Feixia Chu, and Rick H. Cote. The molecular architecture of photoreceptor phosphodiesterase 6 (pde6) with activated g protein elucidates the mechanism of visual excitation. Journal of Biological Chemistry, 294(51):19486–19497, December 2019. URL: http://dx.doi.org/10.1074/jbc.ra119.011002, doi:10.1074/jbc.ra119.011002. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.011002)

[11. (Watson2021Genetic) Christopher J. G. Watson, Benjamin M. Nash, To Ha Loi, John R. Grigg, and Robyn V. Jamieson. Genetic Variants and Impact in PDE6B Rod-Cone Dystrophy, pages 197–206. Springer Singapore, 2021. URL: http://dx.doi.org/10.1007/978-981-15-9184-6_15, doi:10.1007/978-981-15-9184-6_15. This article has 0 citations.](https://doi.org/10.1007/978-981-15-9184-6_15)

[12. (ZengElmore2014Molecular) Xiaohui Zeng-Elmore, Xiong-Zhuo Gao, Riccardo Pellarin, Dina Schneidman-Duhovny, Xiu-Jun Zhang, Katie A. Kozacka, Yang Tang, Andrej Sali, Robert J. Chalkley, Rick H. Cote, and Feixia Chu. Molecular architecture of photoreceptor phosphodiesterase elucidated by chemical cross-linking and integrative modeling. Journal of Molecular Biology, 426(22):3713–3728, November 2014. URL: http://dx.doi.org/10.1016/j.jmb.2014.07.033, doi:10.1016/j.jmb.2014.07.033. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2014.07.033)

[13. (Barren2009Structural) Brandy Barren, Lokesh Gakhar, Hakim Muradov, Kimberly K Boyd, S Ramaswamy, and Nikolai O Artemyev. Structural basis of phosphodiesterase 6 inhibition by the c-terminal region of the γ-subunit. The EMBO Journal, 28(22):3613–3622, October 2009. URL: http://dx.doi.org/10.1038/emboj.2009.284, doi:10.1038/emboj.2009.284. This article has 52 citations.](https://doi.org/10.1038/emboj.2009.284)

[14. (Bolger2021The) Graeme B. Bolger. The pde-opathies: diverse phenotypes produced by a functionally related multigene family. Trends in Genetics, 37(7):669–681, July 2021. URL: http://dx.doi.org/10.1016/j.tig.2021.03.002, doi:10.1016/j.tig.2021.03.002. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tig.2021.03.002)